Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 12,886 | 2,344 | 54,024 | 462 | 122 |
Cost of Goods | 1,551 | 1,454 | 109 | N/A | N/A |
Gross Profit | 11,335 | 890 | 53,915 | 462 | 122 |
Operating Expenses | 177,500 | 150,843 | 148,039 | 167,966 | 127,611 |
Operating Income | -165,614 | -149,499 | -94,015 | -167,504 | -127,489 |
Interest Expense | 15,134 | 11,067 | 10,839 | 9,738 | 10,962 |
Other Income | 28,466 | -450 | 2,780 | 6,160 | 3,426 |
Pre-tax Income | -152,282 | -161,016 | -102,074 | -171,082 | -135,025 |
Net Income Continuous | -152,282 | -161,016 | -102,074 | -171,082 | -135,025 |
Minority Interests | -5,105 | -5,081 | -5,726 | -8,003 | -15,044 |
Net Income | $-147,177 | $-155,935 | $-96,348 | $-163,079 | $-119,981 |
EPS Basic Total Ops | -1.00 | -1.06 | -0.66 | -1.18 | -1.01 |
EPS Basic Continuous Ops | -1.04 | -1.10 | -0.70 | -1.23 | -1.13 |
EPS Diluted Total Ops | -1.00 | -1.06 | -0.66 | -1.18 | -1.01 |
EPS Diluted Continuous Ops | -1.04 | -1.10 | -0.70 | -1.23 | -1.13 |
EBITDA(a) | $-164,088 | $-149,234 | $-90,529 | $-166,938 | $-127,054 |